You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 2, 2026
Exercise
Calculated transaction value
$1.29M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$547.15
Jul 1, 2026
First close after public filing
$547.25
Jul 6, 2026
30-day return after filing
-5.65%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,500 shares @ $135.42
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000090
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.45M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR Current | Exercise | Jul 1, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $217.72K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $440.97K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $822.85K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $418.13K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $477.09K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $282.44K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $479.6K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $614.22K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $530.43K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $669.37K |
| United Therapeutics Corp UTHR | Sale | Jul 1, 2026 | $211.97K |
| United Therapeutics Corp UTHR | Exercise | Jul 1, 2026 | $0 |